Skip to content

M. Genioglossus (GG) response to electrical stimulation of the internal branch of the Superior Laryngeal Nerve (iSLN)

M. Genioglossus (GG) response to electrical stimulation of the internal branch of the Superior Laryngeal Nerve (iSLN)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017744
Enrollment
10
Registered
2019-08-28
Start date
2019-06-17
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.31

Interventions

Group 1: The aim of this clinical investigation is to determine whether the direct electrostimulation of the iSLN is able to increase the activity of the ipsilateral and potentially also the contralat

Sponsors

MED-EL Elektromedizinische Geräte GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Age = 18 years • Patients who, independently from the enrollment in this clinical investigation, are pre-scheduled for an ENT surgery (such as laryngectomies or neck dissections) for which the iSLN exposure is foreseen and for whom, as a consequence of the said pre-scheduled ENT surgery the post-operative functionality of the exposed iSLN is irrelevant • Anatomic, physiological and mental conditions compatible with the participation in this clinical investigation • Signed and dated informed consent before the start of any clinical investigation-specific procedure for all the recruited subjects

Exclusion criteria

Exclusion criteria: • Lack of compliance with any inclusion criteria • Pregnant or breast-feeding women • Other clinical diseases that might result in alteration of the outcomes of this clinical investigation (e.g. other types of dystonia, tremors, etc.) • Use of an active medical implant • Known allergies or intolerance to the material used for this clinical investigation • Parallel participation in a device/drug clinical investigation in the period of data collec-tion, which could confound the results of the clinical investigation 2019CIP001 • Anything that, in the opinion of the Principal Investigator, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this clinical investigation

Design outcomes

Primary

MeasureTime frame
EMG of the genioglossus muscle activity for maximal 1 hour during the direct stimulation of the iSLN (internal Ramus of the superior laryngeal nerve)

Secondary

MeasureTime frame
EMG record of the musculus palatopharyngeus and musculus palatoglossus activity for maximal 1 hour during the direct stimulation of the iSLN (internal Ramus of the superior laryngeal nerve); Video of the stimulation; Stimulation report regarding the tested stimulation settings

Countries

Germany

Contacts

Public ContactJoachim T. Maurer

"Klinik für Hals-Nasen-Ohrenheilkunde,Medizinische Fakultät Mannheim der Universität Heidelberg - Universitätklinikum Mannheim

joachim.maurer@umm.de+49 621 383 3965

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026